Fundamental Analysis
41 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -72.2% | -45.1% | 0 / 3 | +29.4% | -9.81 pp | -6.71 pp | +21.0% | 0.11 | 10.51 | 456 | +29,4% | 8,4 | −72,2% | 10.51 | 9.16 | +14,8% |
| Pts | 0 | 0 | 0 | 12 | 0 | 0 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 58.000 (close price on 2026-10-19)EPS (TTM): 5.517
Financial charts
1.Revenue & growth
VND bn456Q2/26
1.Revenue & growth
VND bn456Q2/26
2.Profit & growth
VND bn8,36Q2/26
3.Profit mix (Penman)
VND bn156Q2/26
4.Margins & cost structure
%18.9%Q2/26
5.Returns & cash cycle
% · days44.3%Q2/26
6.Earnings quality & cash
VND bn148Q2/26
7.Asset structure
VND bn994Q2/26
8.Funding & debt health
VND bn · times994Q2/26
9.Revenue backlog
VND bn18,6Q2/26
10.Valuation
times · %10,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %373Q2/26
Adjusted EPS growth, latest quarter
-72.2%
Average adjusted EPS growth, 3 quarters
-45.1%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26